← All stocks

SUPERNUS PHARMACEUTICALS, INC.

SUPN No buying or selling
CIK 0001356576 #1815 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

11 insiders · 0 transactions
107×

Jack A. Khattar holds 107 times base salary in stock. $111.89M of shares against $1.04M in salary for 2025.

Salary from the company's own proxy. The shares are what Jack A. Khattar last reported holding, valued at $50.48, the price Common Stock was last bought or sold at on the open market here, on 18 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Khattar Jack A.
President, CEO
2,216,451
$111.89M
+13.7%
NEWHALL CHARLES W III
Director
124,119
$6.27M
+2.6%
Hudson Frederick M.
Director
60,413
$3.05M
+62.8%
GEMAYEL GEORGES
Director
27,277
$1.38M
+104.9%
Barlow Carrolee
Director
27,045
$1.37M
+57.2%
Mottola Frank
SVP, Chief Tech. Ops. Officer
19,544
$986.58K
+110.7%
Bhatt Padmanabh P.
Sr. VP of IP, CSO
18,637
$940.80K
+67.3%
Rubin Jonathan
SVP, Chief Medical Officer
13,979
$705.66K
+123.8%
DEC TIMOTHY C
Senior Vice-President & CFO
9,129
$460.83K
+0.6%
Horich William Todd
SVP, Commercial Operations
0
$0.00
−100.0%
Sensenig Bethany
Director
0
$0.00

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 16 Sep 2016